Enter your terms above and click the 'Search' button.

Showing articles 0 to 2 of 2 Filter Applied: cop 1 (Click to remove) Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies JAMA Neurol 77:184-191, Luna, G.,et al, 2020 A 29-Year-Old Man with Multiple Sclerosis JAMA 280:1432-1439, Rudick,R.A., 1998 Showing articles 0 to 2 of 2